Fresh Tracks Therapeutics (FRTX) PT Raised to $9 at Oppenheimer Following Reverse Split
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Fresh Tracks Therapeutics (NASDAQ: FRTX) to $9.00 (from $1.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
